期刊
TRANSLATIONAL RESEARCH
卷 239, 期 -, 页码 85-102出版社
ELSEVIER SCIENCE INC
DOI: 10.1016/j.trsl.2021.01.006
关键词
-
资金
- Instituto de Salud Carlos III-FEDER [PI16/01212, PI19/00305]
- FPU Program (Ministerio de Educacion Cultura y Deporte, Spain)
- Tecnicos bioinformaticos de apoyo a la investigacion en los IIS program by the Instituto de Salud Carlos III [CA18/00026]
- European Social Fund (Investing in your future)
This study characterized the protein cargo of extracellular vesicles (EVs) released by adipose tissue (AT) in obese individuals using mass spectrometry analysis. The results revealed that EVs shed by visceral adipose tissue (VAT) in obese individuals contained more inflammation-related proteins compared to those shed by subcutaneous adipose tissue (SAT). Additionally, specific proteins identified in the EVs were associated with disease status and could serve as candidate biomarkers. These findings provide important insights into the mechanisms underlying obesity and related metabolic disorders.
Extracellular vesicles (EVs) have been recently postulated as key players in metabolic disorders emerging as an alternative way of paracrine/endocrine communication. However, the nature of EVs shed by adipose tissue (AT) and their role in obesity is still very limited. Here, we isolated human morbid obese visceral (VAT) and subcutaneous (SAT) whole AT shed EVs from donors submitted to bariatric surgery to characterize their protein cargo by qualitative and quantitative/SWATH mass spectrometry analysis. We identified 574 different proteins shed by morbid obese VAT and 401 proteins in those from SAT, establishing the first obese AT EV proteome reference map. Only 50% of identified proteins in VAT vesicles were common to those in SAT; additionally, EVs shed by obese VAT showed more AT and obesityrelated adipokines than SAT. Functional classification shows that obese VAT vesicles exhibit an enrichment of proteins implicated in AT inflammation and insulin resistance such as TGFBI, CAVN1, CD14, mimecan, thrombospondin-1, FABP-4 or AHNAK. Selected candidate biomarkers from the quantitative-SWATH analysis were validated in EVs from independent morbid obese and from moderate obese to lean individuals showing that morbid obese VAT vesicles are characterized by a diminution of syntenin 1 and the elevation of TGFBI and mimecan. Interestingly, TGFBI and mimecan containing vesicles could be detected and quantified at circulating level in plasma. Thus, a significant elevation of -TGFBI-EVs was detected on those obese patients with a history of T2D compared to nondiabetic, and an augmentation of mimecan-EVs in obese plasma compared to those in healthy lean individuals. Thus, we conclude that obese AT release functional EVs carrying AT and obesity candidate biomarkers which vary regarding the AT of origin. Our findings suggest that circulating EV-TGFBI may facilitate monitoring T2D status in obese patients, and EVmimecan may be useful to track adiposity, and more precisely, visceral obesity. (Translational Research 2022; 239:85-102)
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据